|
|
|
Volumn 36, Issue 4 SUPPL. 6, 1999, Pages 9-14
|
|
Antisense therapy of hematologic malignancies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGODEOXYNUCLEOTIDE;
OBLIMERSEN;
PROTEIN BCL 2;
PROTEIN BCL X;
PROTEIN KINASE C;
PROTEIN P53;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CANCER REGRESSION;
CONFERENCE PAPER;
DOSE RESPONSE;
DOWN REGULATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
FOLLICULAR LYMPHOMA;
GENE EXPRESSION REGULATION;
GENE SILENCING;
GENE THERAPY;
HEMATOPOIETIC SYSTEM TUMOR;
HUMAN;
MOUSE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ANIMALS;
GENES, BCL-2;
HEMATOLOGIC NEOPLASMS;
HUMANS;
IMMUNOTHERAPY;
OLIGONUCLEOTIDES, ANTISENSE;
|
|
EID: 0032833451
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (55)
|
|
References (29)
|
